pHLIP-Mediated Delivery of PEGylated Liposomes to Cancer Cells by Yao, Lan et al.
University of Rhode Island
DigitalCommons@URI
Physics Faculty Publications Physics
2013
pHLIP-Mediated Delivery of PEGylated
Liposomes to Cancer Cells
Lan Yao
University of Rhode Island
Jennifer Daniels
University of Rhode Island
See next page for additional authors
Follow this and additional works at: https://digitalcommons.uri.edu/phys_facpubs
The University of Rhode Island Faculty have made this article openly available.
Please let us know how Open Access to this research benefits you.
This is a pre-publication author manuscript of the final, published article.
Terms of Use
This article is made available under the terms and conditions applicable towards Open Access Policy
Articles, as set forth in our Terms of Use.
This Article is brought to you for free and open access by the Physics at DigitalCommons@URI. It has been accepted for inclusion in Physics Faculty
Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Yao, L., Daniels, J., Wijesinghe, D., Andreev, O. A., & Reshetnyak, Y. K. (2013). pHLIP®-mediated delivery of PEGylated liposomes to
cancer cells. Journal of Controlled Release, 167(3), 228-237. doi: 10.1016/j.jconrel.2013.01.037
Available at: http://dx.doi.org/10.1016/j.jconrel.2013.01.037
Authors
Lan Yao, Jennifer Daniels, Dayanjali Wijesinghe, Oleg A. Andreev, and Yana K. Reshetnyak
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/phys_facpubs/24
  
 
 
 
 
 
pHLIP

-Mediated Delivery of PEGylated Liposomes to Cancer Cells 
 
 
 
Lan Yao
*
, Jennifer Daniels, Dayanjali Wijesinghe,  
Oleg A. Andreev, Yana K. Reshetnyak 
 
 
Physics Department, University of Rhode Island, 2 Lippitt Road, Kingston, RI 02881, USA 
 
*
Current address: Physics Department, Binghamton University, State University of New York, P.O. Box 
6000, Binghamton, NY 13902, USA 
 
 
 
 
 
Correspondence:  
Yana K. Reshetnyak 
Physics Department 
University of Rhode Island 
2 Lippitt Rd. 
Kingston, RI, 02881, USA 
Tel +1 401 874 2060 
Fax +1 401 874 2380 
E-mail reshetnyak@mail.uri.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
ABSTRACT 
 
We develop a method for pH-dependent fusion between liposomes and cellular membranes using 
pHLIP (pH Low Insertion Peptide), which inserts into lipid bilayer of membrane only at low pH.  
Previously we establish the molecular mechanism of peptide action and show that pHLIP can target acidic 
diseased tissue. Here we investigate how coating of PEGylated liposomes with pHLIP might affect 
liposomal uptake by cells. The presence of pHLIP on the surface of PEGylated-liposomes enhanced 
membrane fusion and lipid exchange in a pH dependent fashion, leading to increase of cellular uptake and 
payload release, and inhibition of cell proliferation by liposomes containing ceramide. A novel type of 
pH-sensitive, “fusogenic” pHLIP-liposomes was developed, which could be used to selectively deliver 
various diagnostic and therapeutic agents to acidic diseased cells. 
 
 
Keywords: acidosis, membrane-associated folding, peptide, fusion, endocytosis, delivery of payload, 
ceramide, pH-sensitive 
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INTRODUCTION 
Liposomes are widely used nanocarries that allow encapsulation of various therapeutics and diagnostic 
agents [1]. Once internalized by cells, liposomes must disrupt or fuse with the endosomal membrane in 
order to release the payload into the cytoplasm. Endosomal trapping of liposomes (and their contents 
within) pose a significant challenge to cytoplasmic delivery of the drug payload. Thus, pH-sensitive 
functionalities have been incorporated into liposomes to promote the mixing of lipids (between the 
liposome and the endosomal membrane) under the acidic environment of the endosomes, which in turn 
facilitates payload release into the cytoplasm [2-8]. Meanwhile, to mask against opsonization and to 
increase circulation time in blood, liposomes are usually coated with poly(ethyleneglycol) (PEG) 
polymers [9-12]. Unfortunately, the presence of PEG on the surface of liposomes hinders drug release, 
even when liposomes have been internalized via receptor mediated endocytosis [13]. One approach to 
avoid this difficulty is to use pH-sensitive PEG polymers that disassemble in the endosomal low pH 
environment, thus exposing lipid bilayer membrane of the liposome for direct interaction with the 
membrane of the endosome [2, 6, 14].  
 
Liposomes can be fashioned into targeted drug carriers. Current targeting strategies usually involve 
conjugation of liposomes with antibodies or other ligands. However, these methods have limitations due 
to the heterogeneous expression of the targeted receptors in diseased tissues. Alternatively, we have 
developed a nanotechnology platform to target the microenvironment of diseased tissues. One of the 
common characteristics of diseased tissues (cancerous tumors, ischemia, inflammation, arthritis, 
atherosclerosis) is an acidic extracellular environment. We designed peptides that insert into cellular 
membranes under slightly acidic pH but not at normal pH. These peptides, called pHLIPs (pH Low 
Insertion Peptides), demonstrated a high ability of targeting acidic tissues in vivo, (including tumors, 
arthritic sites and ischemic myocardium)[15-19]. The targeting mechanism of pHLIP is based on its pH-
triggered insertion into lipid bilayers that ultimately results in the formation of a transmembrane helix 
[20-23]. One promising application is to use pHLIP for targeting liposomes towards diseased tissues. 
Here, new formulations of pH-sensitive, “fusogenic”, PEGylated liposomes are developed by including 
pHLIP in the liposomal coating. We demonstrated that pHLIP-PEG-liposomes bind and fuse with cellular 
membranes at low pH, but not at normal pH, and promote cellular uptake. 
 
MATERIALS AND METHODS 
Materials  
The N-capped pHLIP peptide, Acetyl-NH-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT-
CO2H, was prepared by standard solid phase synthesis and purified at the W.M. Keck Foundation 
Biotechnology Resources Laboratory at Yale. The lipids, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene 
glycol)-2000](ammonium salt) (DSPE-PEG2000-Maleimide), 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-[lissamine rhodamine B sulfonyl] (Rhod-PE), N-octanoyl-
sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]} (C8-PEG750 ceramide) and N-hexanoyl-D-
erythro-sphingosine (C6 Ceramide), were purchased from Avanti Polar Lipids, Inc (Alabaster, AL). The 
fluorescein labeled lipids, N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (FITC-DHPE), rhodamine labeled fatty acid, octadecyl 
rhodamine B chloride (R18), and fluorescent dyes: Wheat germ agglutinin Texas Red, ER-tracker green, 
mito-tracker deep red, 8-aminonaphthalene-1,3,6-trisulfonic acid, disodium salt (ANTS) and p-xylene-
bis-pyridinium bromide (DPX) were from Life Technologies (Carlsbad, CA) . The fatty acid conjugated 
with 1.4 nm gold nanoparticles, palmitoyl nanogold and HQ Silver
TM
 Enhancement Kit were purchased 
from Nanoprobes, Inc (Yaphank, NY). DNA staining dye, propidium iodide (PI), was from Sigma-
Aldrich Co, LLC (St. Louise, MO). 
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Synthesis of DSPE-PEG2000-pHLIP 
DSPE-PEG2000-pHLIP was synthesized by the covalent conjugation of DSPE-PEG2000-maleimide with 
the single cysteine residue at the N-terminus of pHLIP. In a typical coupling reaction, 600 nmol of 
peptide was mixed with 500 nmol of DSPE-PEG2000-Maleimide in 200 µL of methanol and left for 
overnight stirring at room temperature under argon. The existence of the product was ensured by SELDI-
TOF mass-spectrometry analysis. 
 
Liposome preparation  
Liposomes were prepared by extrusion. A chloroform solution of the desired lipid mixture (1 μmol) 
including solution of DSPE-PEG2000-pHLIP in methanol was vortexed and evaporated using rotary 
evaporator, producing an even thin film. pHLIP is an unstructured peptide, which could be dissolved in 
organic solvents including methanol and chloroform. The lipid film was left under a vacuum for overnight 
to remove residuals of organic solvent. The hydration of the dry lipid film was accomplished by adding 1 
mL of stock buffer solution (10 mM phosphate, 150 mM NaCl, pH 8) to the flask of lipids and agitating. 
Typically, a hydration time of 1 hr with vigorous vortexing was needed for pHLIP-containing liposome. 
After 10 freeze-thaw-vortex cycles, the resulting multilamellar liposome solution was extruded 15 or 31 
times through 50, 100 or 200 nm polycarbonate filters and sterilized by filtering through 0.2 μm filter. 
The final lipid concentration was re-calculated by knowing the concentration of fluorescent lipids, which 
was obtained spectrophotometrically. Small amount of liposomes were diluted in methanol and 
absorbance of rhodamine (ε556=125,000 M
-1
cm
-1
)
 
or fluorescein (ε495=88,000 M
-1
cm
-1
) was measured. 
When loading with propidium iodide (PI), ANTS or DPX was required, PI (4 mM), ANTS (25 mM) or 
DPX (90 mM) were added as a component of the rehydration solution. After liposome extrusion, free PI, 
ANTS or DPX were removed by dialysis using dialysis tube with MWCO of 8000 Da, followed by 
stirring in 1 L buffer solution for 24 hrs with 3 times buffer refreshing, or by fast spin semi-dry column 
using sephadex G25. In each case we ensure that ionic strength of solution within liposomes was the same 
as outside of liposomes. The ionic strength was regulated by addition of NaCl.  
 
Cryo-electron microscopy  
About 5 µL droplet of liposome solution was spread on an electron microscopy grid and preserved in a 
frozen-hydrated state by a rapid freezing in liquid ethane. The vitrification process was performed via FEI 
Vitrobot System (Hillsboro, OR), with the setting of a single blot of 3 sec, an offset of -1, and drain and 
wait time of 1 sec. Samples were imaged using JEOL 2100 TEM with an accelerating voltage of 200 kV 
at magnifications of 20,000x and 40,000x. 
 
DLS measurements 
The size of liposomes was measured by dynamic light scattering (DLS) using a Malvern Zetasizer Nano 
ZS instrument with Malvern disposable cuvettes (Malvern USA, Southborough, MA) right after the 
extrusion of liposomes and in some cases, within a week after preparation. Samples were typically 200 
nmol liposomes in 1 mL of aqueous buffer (10 mM phosphate, 150 mM NaCl, pH 8.0). 
 
Inter-liposomal fusion assay  
R18-labeled liposomes (50 µL, 200 µM) were mixed with an equal volume of unlabeled POPC vesicles 
(lipid concentration was varied from 0 to 6 mM) in an aqueous buffer (10 mM phosphate, 150 mM NaCl, 
pH 8.0). The R18 fluorescence intensity was monitored on an ISS spectrofluorometer (Champaign, IL) at 
excitation and emission wavelengths set at 556 nm, and 590 nm, respectively, as the pH was lowered 
from 8 to 4 (via addition of small amounts of HCl). A circulating water bath was connected to cuvette 
holder to control sample temperature at 22C. Complete fusion and mixing of lipids was achieved via 5 
freeze-thaw cycles, the fluorescence intensity obtained afterwards was defined as ‘100% fusion’. The 
degree of liposome fusion in % was calculated according to the equation: 
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where F0 is the initial fluorescent intensity of liposome mixture at pH8 (no fusion), Fmax is the maximum 
fluorescent intensity of liposome mixture at pH 4 after 5 freeze-thaw cycles (100% fusion), and F is the 
fluorescent intensity of liposome mixture at pH 4 before freeze-thaw cycles. 
 
In other fusion assay, 100 M of 50 nm DOPC liposomes of ‘5:5’ formulation containing 5% R18 and 
encapsulated with 25 mM of fluorescent dye ANTS were mixed with equal volume of 2 mM of 200 nm 
POPC liposomes encapsulated with 90 mM of DPX, which is a quencher of ANTS fluorescence, in the 10 
mM phosphate buffer of pH 8 containing of 40 mM NaCl. The pH was reduced by addition of aliquot of 
concentrated HCl. The increase of R18 fluorescence signal and decrease of ANTS signal due to the 
liposome fusion and mixing of ANTS with DPX were observed on the same liposomes. ANTS 
fluorescence was excited at wavelength of 360 nm and observed at 530 nm.  In addition, changes of 
scattering signal monitored at 650 nm with excitation at 650 nm were recorded.  
  
Cell lines 
Lung carcinoma A549 and human cervix adenocarcinoma HeLa cell lines were obtained from American 
Type Culture Collection (Manassas, VA). Cells were authenticated, stored according to supplier’s 
instructions, and used within 3-4 months after frozen aliquots resuscitations. Cells were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum, 10 μg/mL of 
ciprofloxactin in a humidified atmosphere of 5% CO2 and 95% air at 37°C. By serial passages some cells 
were adapted for the growth in low pH medium (pH 6.5). The pH 6.5 media was prepared by mixing 13.5 
g of dry DMEM powder with 0.2 g of sodium bicarbonate in 1 L of deionized water. 
 
Cellular uptake of fluorescently labeled liposomes 
Typically, a suspension of A549 cells was prepared by dissociating 4-6 days old monolayer grown in 
75cm
2
 flask with trypin, EDTA (Gibco, Gaithersburg, MD). Trypsinized cells were counted using a 
hemacytometer and diluted to 1 x 10
6
 cells/mL in serum-free media (for 1 hr incubation) or PBS (for 15 
min incubation) as stock solutions. The liposomes (20 nmol), containing fluorescent probe lipids or fatty 
acid, were incubated with 2 x 10
5
 cells in 1 mL of the desired solution for 1 hr or 15 min at 37°C or 4°C.  
In some studies, ATP-depleting media (DMEM + 20 mM NaN3/ 50 mM 2-deoxy-glucose) was added for 
1 hr at 37°C prior to liposome addition and was kept throughout the liposome incubation period. After 
incubation, the cells were pelleted by centrifugation (2000 rpm, 4 min) at room temperature (or 4°C). 
Then the supernatant was removed and the pellet was resuspended in 1 mL of fresh serum-free media (or 
PBS) and centrifuged second time. The second pellet was resuspended in 100 µL of the same media. 
Sequentially, 20 µL of the cell suspension solution was loaded into a counting chamber and the 
fluorescent signal of individual cells was measured using Nexcelom Cellometer Vision (Lawrence, MA). 
For each measurement, fluorescent data of 2000-3000 cells were obtained and statistically analyzed. All 
samples were prepared at least in triplicate for each formulation of liposomes. The fluorescent signals of 
untreated cells were used as a common divisor for normalization of all the fluorescent data in each assay. 
Cell viability was confirmed by addition of trypan blue to cell sample. After cellometer counting, the 
residual cells were reseeded in collagen-coated cell dishes and viewed under the microscope after 24, 48 
and 72 hrs. 
 
Fluorescence microscopy 
HeLa and A549 cells adapted for low pH growth (pH 6.5 and pH 6.2, respectively) were seeded in 
collagen-coated cell dishes (5,000 and 15,000 cells/dish, respectively). After 24 hr the culture medium 
was removed and cells were incubated with 6 nmol of fluorescein-labeled liposome, DOPC/DSPE-
PEG2000-pHLIP/DSPE-PEG2000/fluorescein-DHPE (85:5:5:5) in 240 L of PBS (pH 6.3) for 1 hr at 37°C 
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under 5% CO2, followed by 3 times washing with sterile PBS (pH 7.4). Sequentially, wheat germ 
agglutinin Texas Red (10 g/mL) was used to stain the plasma membranes of live cells for co-localization 
studies. For the cells treated with R18 labeled liposome, ER-tracker green and Mito-tracker Deep Red FM 
were used to stain endoplasmic reticulum (ER) and mitochondria of live cells. Fluorescent images were 
acquired with a Retiga CCD camera (Qimaging, Burnaby, BC, Canada) mounted to an inverted Olympus 
IX71 microscope (Olympus America, Inc., Center Valley, PA). Fluorescent images from different stains 
were obtained in the same field of view with corresponding filters. 
  
Cellular uptake of nanogold labeled liposomes 
A549 cells adapted for low pH media, grown to 80-90% confluence on 8-well chamber slide were 
incubated in 200 L serum-free DMEM (pH 6.5) with 12 nmol of nanogold labeled liposome for 15 min 
at 37°C under 5% CO2. After incubation, the medium was removed and cells were washed three times 
with sterile PBS (pH7.4) and fixed in cold methanol for 10 min, followed by washing twice with sterile 
PBS (pH7.4) and once with distilled H2O. After air-drying, cells were treated with silver enhancement 
solution (following manufacture’s instruction) and viewed under the light microscope. 
 
Delivery of PI  
A549 cells adapted for low pH media were seeded in collagen-coated cell dishes (5,000 cells/dish). After 
24 hrs, the culture medium was removed and cells were treated with 10 nmol of PI loaded liposome 
DOPE / pHLIP-PEG-DSPE / DSPE-PEG2000 / fluorescein-DHPE (85:5:5:5 or 85:0:10:5) in 100 L of 
serum-free DMEM (pH 6.5) for 1 hr at 37°C under 5% CO2. After incubation, the medium was removed 
and cells were washed three times with sterile PBS (pH 7.4) and viewed under fluorescence microscope. 
 
Cytotoxicity Assay 
A549 cells grown in standard growth medium of pH 7.4 and A549 cells adapted for low pH (pH 6.2) 
growth medium were loaded in the wells of 96-well plates (~5,000 and 7,000 cells per well, respectively) 
and incubated overnight. Next day cells were treated with increasing concentrations (0, 10, 50, 100, 200, 
400 μM) of DOPE and DOPC/pHLIP-PEG-DSPE/DSPE-PEG2000 (85:5:5:5 or 85:0:10:5) for 2 hrs 
followed by the addition of equal volume of growth medium with 20% of serum of the same pH (to have 
10% FBS of final concentration, since constructs were not removed). Cell viability was assessed after 1 
and 2 days of incubation with constructs using the colorimetric reagent (CellTiter 96 AQueous One 
Solution Assay, Promega), which was added for 1 hr to cells followed by measuring absorbance at 490 
nm. All samples were prepared in triplicate. 
 
Inhibition of cell proliferation by liposomal ceramide 
A549 cell suspension (160,000 cells) were incubated with 160 nmol of liposomal ceramide in 1 mL of 10 
mM phosphate buffer (150 mM NaCl, 1 mM MgCl2 and 1 mM CaCl2) at pH 6.1 or pH 8 for 1 hr at 37°C 
under 5% CO2. After incubation, cells were pelleted by centrifugation (2000 rpm, 4 min) at room 
temperature followed by the removal of supernatant. The pellet was resuspended in 1 mL of fresh serum-
free media and centrifuged second time. The second pellet was reseeded into 96-well tissue culture plates, 
5,000 cells per well with 250 L medium. After 72 hrs, the medium was removed and Cell Titer 96 
Aqueous One solution (Promega Co., Madison, WI) was added to each well. The viability of cells was 
measured by using a SpectraMax plate reader (Molecular Devices, Inc. Sunnyvale, CA) at 490 nm. 
Relative viability was calculated with cells treated only with medium alone as a control.  
 
RESULTS  
Liposome composition and characterization 
The main goal of our investigation is to demonstrate that pHLIP can promote cellular uptake of 
PEGylated liposomes and enhance lipid mixing and fusion between liposomal and cellular membranes. It 
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is well established that PE lipids (such as DOPE), which are minimally hydrated and have small 
headgroups, possess high fusogenic propensity [24]. In our study, we tested both fusogenic (DOPE-based) 
and non-fusogenic (DOPC-based) liposomes.  
 
To introduce pHLIP in a liposome coat, we conjugated DSPE-PEG2000maleimide lipid with Cys residue in 
the N-terminal region of pHLIP. Due to the fact that pHLIP is an unstructured polypeptide, it could be 
dissolved in organic solvent with no harm to its structure. The conjugation product was characterized by 
SELDI-TOF mass spectrometry (Figure 1). The narrow peak at 4154 Da corresponds to pHLIP, and the 
broad peak centered at ~7000 Da corresponds to the conjugation product DSPE-PEG2000-pHLIP. DSPE-
PEG2000-pHLIP was used for preparation of liposomes containing pHLIP. The detailed composition of 
liposomes used in the study is given in Table 1. The first number in the formulation code refers to the 
mole percentage of pHLIP-PEG lipids (DSPE-PEG2000-pHLIP), whereas the second number refers to the 
amount of PEG lipids (DSPE-PEG2000). The different formulations of liposomes were characterized by 
cryo-TEM and DLS. Special attention was given to the stability of DOPC/DOPE ‘5:5’ and ‘10:0’ 
formulations containing 5% and 10% DSPE-PEG2000-pHLIP, respectively. The average size of DOPC and 
DOPE liposomes of ‘5:5’ formulation was about 125 nm in diameter with PDI (polydispersity index) of 
about 0.06 and Zeta potential of about -16 mV. The measurements were performed within several days 
after liposomes preparations and numbers represent averaged values. The average size of DOPE and 
DOPC liposomes containing 10%  DSPE-PEG2000-pHLIP was larger in size. The DOPE liposomes, were 
stable for several days with average size of 150 nm, PDI of 0.06 and Zeta-potential of -19.5 mV. 
However, the DOPC‘10:0’ liposome formulation was very unstable with increased size of liposomes of 
200 nm.  Figure 2 shows cryo-TEM images of DOPC / DOPE liposomes with and without pHLIP in 
liposome coat. These liposomes have formulations “0:10” (an example of a control liposome without 
pHLIP) and “5:5” (an example of a pHLIP-containing liposome) (Table 1). The TEM images illustrate 
that our liposome samples consist of a mixture of small unilamellar (<100 nm) and multilamellar vesicles, 
mostly with two bilayers (~100 nm). pHLIP-containing liposomes show more complex multilamellar 
structures, especially for liposomes consisting of fusogenic DOPE lipids (Figure 2B), which is most 
probably due to the pHLIP-induced membrane fusion. Since pHLIP has high affinity to the lipid bilayer 
of membrane, fusion promoted by pHLIP results in formation of multilamelar structures rather than 
bigger liposomes. Such multilamelar structures allow interaction of pHLIP peptides with lipid bilayer of 
the same liposome. 
 
 
 
Figure 1.  SELDI-TOF mass spectrum of DSPE-PEG2000-pHLIP. The narrow peak at 4154 
corresponds to the pHLIP peptide. The broad peak centered at ~7000 Da corresponds to the conjugated 
product DSPE-PEG2000-pHLIP. The individual spikes on the broad peak differ from each other by the 
repeating unit(s) of PEG (mass: 44 Da). The marked mass at 7029 corresponds to the expected mass of 
the product minus one unit of PEG (7074 – 44 = 7030 Da). 
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Table 1. Formulation of liposomes used in various experiments 
Formulations of fluorescently labeled liposomes  
Liposome code
a
  ‘0:10’ ‘1:9’ ‘5:5’ ‘10:0’ ‘0:5’ ‘1:4’ ‘5:0’ ‘0:1’ ‘1:0’ 
DOPC (or DOPE)  83%
b
 83% 83% 83% 88% 88% 88% 92% 92% 
DSPE-PEG2000-pHLIP 0% 1% 5% 10% 0% 1% 5% 0% 1% 
DSPE-PEG2000  10% 9% 5% 0% 5% 4% 0% 1% 0% 
Fluorescent lipids
c
  7% 7% 7% 7% 7% 7% 7% 7% 7% 
Formulations of nanogold labeled liposomes 
   Control-liposome  pHLIP-liposome  
DOPE    86%    86%  
DSPE-PEG2000  10%    0%  
DSPE-PEG2000-pHLIP 0%    10%  
Palmitoyl Nanogold  2.5%    2.5% 
R18    1.5%    1.5%  
Formulations of ceramide liposome 
  Control-liposome  pHLIP-liposome  
DOPC    37%    37% 
DOPE    17.5%    17.5%  
DSPE-PEG2000  7.5%    2.5%  
DSPE-PEG2000-pHLIP 0%    5%  
C8-PEG750 ceramide  7.5%    7.5% 
C6 ceramide   30%    30% 
R18    0.5%    0.5%  
Notes:  
a. Ratio in liposome code refers to molar ratio between pHLIP-PEG-lipids and PEG-lipids.  
b. Percentages indicate mole fractions.  
c. Fluorescent lipids are R18, Rho-PE, or fluorescein-DHPE.  
 
 
 
 
Figure 2. Cryo-TEM images of R18-
labeled liposomes. The control 
liposomes without pHLIP are shown 
on panels (A) (DOPE/DSPE-
PEG2000/R18, 83:10:7) and (C) 
(DOPC/DSPE-PEG2000/R18, 83:10:7); 
and the pHLIP coated liposomes are 
shown on panels (B) (DOPE/DSPE-
PEG2000/DSPE-PEG2000-pHLIP/R18, 
83:5:5:7) and (D) (DOPC/DSPE-
PEG2000/DSPE-PEG2000-pHLIP/R18, 
83:5:5:7). The images were obtained 
using JEOL 2100 TEM with an 
accelerating voltage of 200 kV. The 
total lipid concentration of samples 
shown is 1 mM. 
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Inter-liposomal fusion  
First, we investigated pHLIP-induced membrane fusion on the model system of phospholipid vesicles. 
Inter-liposomal fusion was monitored by fluorescence increase of octadecyl rhodamine B (R18), which 
was part of liposome composition. When rhodamine dye molecules are in close proximity to each other, 
such as in the case of high concentration (7 mol % of R18) in two-dimensional membrane space, the self-
quenching occurs [25]. The fluorescence increase is observed when liposomes containing R18 fuse with 
unlabeled POPC liposomes, which leads to the decrease of effective concentration of R18, that is, an 
increase of averaged distance between rhodamine dyes. Four types of R18-labeled liposomes were 
studied, i.e. DOPC- or DOPE-based PEG-liposomes with or without pHLIP (Figure 3).  
 
Typical changes of R18 fluorescence are shown in Figure 3A. The fluorescence signal of solution 
containing unlabeled POPC liposomes (6 mM) mixed with an equal volume of R18-labeled liposomes 
(200 μM) at pH 8 was taken as 0% of fusion. After equilibrating at pH 8 for ~ 2 min, the pH was dropped 
from 8 to 4, and increase of fluorescence indicating on fusion was observed only for liposomes containing 
pHLIP in coat. Non-physiological pH 8 and pH 4 in this model assay on liposomes were used to ensure 
that all pHLIP molecules exist in either state II or state III, respectively. Fluorescence signal measured 
after 5 freeze-thaw cycles was taken as 100% of fusion. Furthermore, we investigated dependence of 
fluorescence increase on amount of unlabeled POPC liposomes (Figure 3B). Mixing of R18-liposomes 
containing pHLIP with increasing concentrations of unlabeled POPC liposomes led to the enhancement of 
de-quenching, indicating that more inter-liposomal fusion had occurred. On the contrary, control 
liposomes (without pHLIP) showed no fluorescence change as the concentration of unlabeled POPC 
increased. Thus, inter-liposomal fusion is strongly dependent on the presence of pHLIP. 
 
To confirm that increase of R18 fluorescence is associated with fusion, not just flip-flopping of R18 we 
performed another fusion assay. 50 nm DOPC liposomes of ‘5:5’ formulation encapsulated with 
fluorescent dye ANTS were mixed with 200 nm POPC liposomes encapsulated with DPX, quencher of 
ANTS fluorescence. The fluorescence signal of ANTS was decreased only when pH was reduced from 8 
to 4 (Figure 3C). The decrease of ANTS emission could occur only in the result of fusion of liposomes 
and mixing of ANTS with DPX.   
 
pHLIP-mediated inter-liposomal association (‘sticking’) takes place at pH 8, since binding of pHLIP to 
lipid bilayer at pH8 (without insertion into membrane) is associated with energy release of about 6 
kcal/mol [23]. At the end of the equilibration period of 2 min at pH 8, most of pHLIP peptides could be 
associated with an inter-liposomal POPC membrane, and the subsequent pH drop triggers membrane 
fusion, since pHLIP inserts into bilayer and adopts TM configuration within about 60 sec after changes of 
pH [22].  The peptide inserted state is stabilized by release of additional 2 kcal/mol of energy [23]. Our 
data indicate that most of pHLIPs prefer the inter-liposomal POPC membrane surface over its own intra-
liposomal DOPE or DOPC surface, which is perhaps because adequate level of PEGylation effectively 
shields the intra-liposomal membrane from association with pHLIP. However, we cannot exclude that 
some amount of peptides inserts in membranes of their own liposomes as well. 
 
The effect of PEGylation level (1-10 mol %), pHLIP content (1-10 mol %), and liposome type (DOPC vs. 
DOPE) on the efficiency of inter-liposomal fusion was further investigated (Figure 3D). We established 
that 5 mol % of PEG2000 is an optimal level of PEGylation. This level of PEGylation roughly 
corresponds to the transition between the tight packing ‘brush’ conformation and the loose ‘mushroom’ 
conformation of the liposomal PEG shield [26]. A lower level of PEGylation at 1 mol % led to the 
reduction of fusion for both DOPC and DOPE pHLIP-liposomes. In this case, we suspect that the 
membrane surface is not adequately shielded by PEG and too many pHLIP molecules associate and insert 
into the intra-liposomal DOPC/DOPE membrane at pH 8 and 4, respectively. However, more PEGylation 
at 10 mol % also led to lesser inter-liposomal fusion, especially for DOPC pHLIP-liposomes, perhaps  
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Figure 3. Inter-liposomal fusion assays. (A) Increase of rhodamine fluorescence reflects fusion of 
membranes. The fluorescence changes were monitored in the solution of R18-labled DOPC or DOPE 
liposomes with or without pHLIP in liposome coat (200 µM total lipid concentration) mixed with equal 
volume of 6 mM POPC at pH 8. The addition of POPC liposomes to the solution of R18-labeled DOPC 
or DOPE liposomes at pH 8 leads to the fluorescence decrease due to the dilution (data not shown). 
Spectral signal at pH 8 was taken as ‘0% fusion’, the fluorescence was monitored several minutes after 
pH drop to pH 4, followed by 5 freeze-thaw cycles performed to induce complete fusion (‘100% fusion’). 
Liposome formulations are ‘5:0’ (with pHLIP) and ‘0:5’ (without pHLIP). (B) Dependence of 
fluorescence intensity changes of rhodamine on concentration of POPC liposomes when mixed with 200 
µM (total lipid concentration) of R18-labled DOPC or DOPE liposomes with or without pHLIP in 
liposome coat. Liposome formulations are ‘10:0’ (with pHLIP) and ‘0:10’ (without pHLIP). (C) To 
confirm that increase of rhodamine fluorescence occurs due to fusion of liposomes, another assay was 
carried. 50 nm DOPC liposomes of ‘5:5’ formulation with entrapped ANTS at pH 8 were mixed with 200 
nm POPC with entrapped DPX, a quencher of ANTS fluorescence. The DOPC liposomes also contained 
5% of R18. The increase of rhodamine fluorescence in a result of pH drop from pH 8 to pH 4 (red line) 
was accompanied by the decrease of ANTS fluorescence (black line) in a result of liposomes fusion and 
mixing of ANTS and DPX. (D) The efficiency of pHLIP-mediated inter-liposomal fusion depends on the 
amount of PEGylated lipids (with 5 mol % of PEG-lipids as the optimal). The detailed formulation of 
liposome composition is presented in Table 1. 
 
 
because shielding of the DOPC surface is too complete and membrane fusion becomes difficult. At 10 
mol % PEGylation, DOPE-based liposomes show higher percentage of fusion than DOPC-based 
liposomes (35% vs. 12 %), in agreement with the fusogenic nature of PE lipids. However, when the 
amount of PEGylation is reduced to 5 mol %, DOPC-based pHLIP-liposomes are just as adapt at 
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membrane fusion as DOPE-based liposomes. Given the same overall amount of PEGylated lipids, (1, 5, 
or 10 mol %), the presence of more pHLIP molecules always correlate with higher levels of membrane 
fusion, except of DOPC liposomes containing 10% of PEG-pHLIP (compare to DOPC liposomes 
containing just 5% of PEG-pHLIP), which most probably is associated with pure stability of this 
particular formulation. Therefore all experiments on cells were performed with liposomes containing no 
more than 5% of PEG-pHLIP. 
 
 
Cellular uptake of liposomes 
Cellular toxicity of liposomes with (‘5:5’) or without (‘0:10’) pHLIP was tested on A549 cells at both pH 
6.2 and pH 7.4. Cells were treated with increasing concentrations of liposomes (up to 400 µM of lipids) 
for 1 and 2 days followed by standard MTS assay to check cells viability. No any cellular toxicity was 
observed  (data not shown). 
 
Membrane fusion between liposomes and cells was evaluated in a cell suspension assay. A549 cells in 
suspension were treated with fluorescently labeled pHLIP-liposomes (“DOPE+pHLIP” or 
“DOPC+pHLIP”) or control-liposomes without pHLIP (“DOPE” or “DOPC”) under various conditions. 
After washing, fluorescence of individual cells was counted using a cellometer. The average fluorescence 
of ~ 2000 treated cells was calculated and normalized to that of untreated cells.  First, we investigated 
whether pHLIP can induce membrane fusion between liposomes and cells in a pH-dependent fashion. 
A549 cells were treated with R18-labled DOPC or DOPE liposomes with or without pHLIP at pH 7.4 or 
6.5. Incubation with cells was either 15 min in PBS (Figure 4A) or 60 min in serum-free DMEM (Figure 
4B). For DOPC liposomes at pH 7.4, no difference in fluorescence intensity was observed between cells 
treated with pHLIP-liposomes vs. cells treated with control liposomes. However, at pH 6.5, the presence 
of pHLIP increased the amount of lipid mixing between liposomes and cell. The difference in cellular 
uptake of DOPE-based liposomes with and without pHLIP was observed already at pH 7.4, while the 
effect became more pronounced at pH 6.5. The results support the idea that pHLIP insertion into cellular 
membrane at low pH can facilitate uptake of liposomes by cells. Due to the fusogenic nature of DOPE 
lipids, DOPE-based liposomes show much higher cellular uptake than DOPC-based liposomes in general, 
which is in agreement with the data of inter-liposomal fusion assay discussed previously. The different 
incubation time of 15 min vs. 60 min might reflect different pathways of liposome-cell interaction. During 
short incubation period, predominantly direct liposomal fusion with plasma membrane occurs; while 
during long incubation period,  both fusion and cellular internalization through endocytosis (most 
probably, macropinocytosis) could happen. Our data show that the fluorescence signal is significantly 
higher at longer incubation time, especially at low pH, suggesting that endocytosis plays an important role 
in pHLIP-mediated cellular uptake of liposomes.  
 
Next, cell treatment was carried out at low temperature or in an ATP-depletion medium to reduce energy 
dependent endocytic uptake. The decrease of temperature significantly (~ 80%) reduced overall liposome 
uptake (Figure 4C). Regardless of the route of entry (being endocytosis or direct interaction with plasma 
membrane), first, pHLIP needs to insert into the cellular membrane in an environment of low pH. Our 
kinetics studies indicate that the rate of insertion is reduced with decrease of temperature [22]. Therefore, 
we assume that experiments at low temperature would affect both fusion, and endocytotic pathways of 
liposomal uptake. Results from the experiments of cells treated at pH 6.5 for 60 min in the ATP depletion 
medium or serum-free DMEM (Figure 4D), indicate that endocytosis is responsible for ~ 50% of pHLIP-
mediated cellular uptake of liposomes. 
 
How does the amount of pHLIP and PEG present on liposome coat influence the level of cellular uptake 
of liposomes? To investigate this question, cells were incubated with DOPC-liposomes of various 
compositions in serum-free DMEM at pH 6.5 for 60 min. When the total amount of PEG-lipids was held 
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constant, the presence of more pHLIP led to higher cellular uptake (Figure 4E, dark grey bars within the 
10 mol % total PEG-lipid series). Furthermore, less amount of PEGylation was more favorable for 
membrane fusion, resulting in higher cellular uptake (Figure 4E, 1 mol % vs. 10 mol %). The results are 
consistent with the data obtained in inter-liposomal fusion assay. 
 
The uptake of liposomes was accessed using the fluorescence of Rho-FA (R18). In place of R18, we also 
incorporated rhodamine-PE or fluorescein-DHPE into the liposomes as alternative fluorescent probes. 
Cells were incubated with DOPC-liposomes with or without pHLIP in serum-free DMEM at pH 6.5 for 
60 min. A similar pattern of pHLIP-dependent cellular uptake of liposomes was observed regardless of 
fluorescent lipid probe used (Figure 4F). Therefore, pH- and pHLIP-dependent cellular uptake of 
liposomes is not influenced by the choice of the fluorescent lipid. 
 
 
 
Figure 4. Cellular uptake of liposomes. A549 cells in suspension were treated with fluorescently labeled 
liposomes (DOPC or DOPE) with or without pHLIP in liposome coat under various conditions. Cellular 
uptake of fluorescent liposomes was accessed by counting of fluorescent cells on a cellometer. All data 
were normalized to the fluorescence intensity of untreated cells (dotted line). (A-B) pH- and pHLIP-
dependent cellular uptake of liposomes is shown. Cells were incubated with R18-labeled liposomes with 
(‘5:5’) or without (‘0:10’) pHLIP in liposome coat at pH 7.4 or 6.5 in PBS for 15 min (A) or in serum-free 
DMEM for 60 min (B). (C-D) Cells were incubated with R-18 labeled liposomes at pH 6.5 in PBS at 4°C 
or 37°C for 15 min (C) and in serum-free DMEM or ATP depletion medium at 37°C for 60 min (D). Low 
temperature and ATP depletion medium are used to reduce endocytotic uptake. (E) Cellular uptake of 
DOPC liposomes (pH 6.5, DMEM, 37°C, 60 min) depends on amount of pHLIP and PEG in liposome 
coat. (F) The pH- and pHLIP-dependent cellular uptake does not depend on choice of fluorescent lipids. 
Liposomes (‘5:5’ DOPC) containing different fluorescent lipids—Rho-FA (R18), Rhodamine-PE (Rho-
lipid), or Fluorescein-DHPE (FITC-lipid)—were incubated with cells (pH 6.5, DMEM, 37°C, 60 min), 
and pHLIP-dependent fluorescence increase was observed in each case. 
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Fluorescence microscopy 
Fluorescent lipids incorporated in liposomes allow visualization of liposome-cell interactions using 
fluorescence microscopy. A549 cells in suspension were incubated with DOPE liposomes with or without 
pHLIP in serum-free DMEM medium at pH 6.5 for 1 hr. After washing, treated cells were grown on 
collagen-coated dishes and became adherent. The light (Figure 5A-a, -c) and fluorescent images (Figure 
5A-b, -d) were taken 4 days after cell treatment with liposomes. Cells treated with pHLIP-containing 
liposomes show much stronger fluorescence than cells treated with liposomes containing no pHLIP. It is 
evident that R18 of liposomes containing pHLIP targeted specific cellular compartment. To figure out 
what organelle was marked by R18 fluorescence, cells treated with pHLIP-liposomes containing R18 
(Figure 5B-b) were labeled with Mito-tracker and ER-tracker to stain mitochondria (Figure 5B-a) and 
endoplasmic reticulum (data not shown), respectively. The co-localization study reveals that the R18 
(Figure 5B-b) was co-localized in mitochondria (Figure 5B-c, 5B-d). R18 contains a hydrophobic lipid 
tail and rhodamine ester, which is positively charged at physiological pH. It is well known that such 
amphiphilic molecules specifically target mitochondria in living cells [27-30]. It is important to outline 
that effective mitochondria targeting by R18 was observed mostly in case of pHLIP-mediated uptake of 
liposomes by cells. 
 
Liposomes containing a different rhodamine lipid probe, Rhod-PE, were also investigated. In this case, 
the rhodamine portion of the molecule is zwitterionic and neutral, (while the overall molecule is -1 
negatively charged due to the phosphate anion in the lipid headgroup). Adherent A549 cells were 
incubated with Rhod-PE labeled liposomes with or without pHLIP in PBS at pH 6.3 for 30 min, and 
distribution of fluorescent signal was monitored under microscope immediately after cell washing. 
Compared to cells treated with control liposomes without pHLIP (Figure 5C-b), cells treated with pHLIP-
containing liposomes (Figure 5C-d) were more fluorescent and have different distribution of fluorescent 
signals. Unlike R18, Rhod-PE lipids do not stain mitochondria, but instead accumulate in perinuclear 
region and plasma membranes (Figure 5C-d). By contrast, punctate staining was observed for cells treated 
with liposomes without pHLIP (Figure 5C-b), indicating endosomal trapping of liposomes. 
 
In addition, liposomes containing fluorescein-DHPE probes (5 mol %) were also tested. Adherent A549 
cells were treated with fluorescein-labeled pHLIP-containing DOPC liposomes in PBS, pH 6.2, for 1 hr 
(Figure 5D-a) and the same cells were stained with wheat germ agglutinin conjugated with Texas Red to 
visualize plasma membrane (Figure 5D-b). It is clearly seen that the plasma membrane of cells treated 
with pHLIP-containing liposomes was stained with fluorescein lipids, revealing that pHLIP induced 
fusion between liposome and plasma membrane. 
 
Finally, instead of fluorescent probes, nanogold particles (1.4 nm) conjugated to fatty acid, were 
introduced in liposome coat. Adherent A549 cells were treated with nanogold-containing DOPE 
liposomes with or without pHLIP in serum-free DMEM at pH 6.5, for 15 min, followed by fixation and 
silver enhancement to enlarge nanogold particles up to micron size particles and visualize them under 
light microscope. Liposomes containing pHLIP delivered more nanogold to cells (Figure 5E-b) than 
liposomes without pHLIP (Figure 6E-a). Similar to the localization of Rhod-PE probe, nanogold particles 
are clearly visible at perinuclear region and plasma membranes of treated cells. 
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Figure 5. Cellular localization of liposomes. (A) A549 cells in suspension were incubated with R18 
DOPE liposomes with (c & d: ‘5:5’) or without pHLIP (a & b: ‘0:10’) in liposome coat in serum-free 
DMEM medium at pH 6.5 for 1 hr. The light (a, c) and fluorescent images (b, d) were taken 4 days after 
cell treatment with liposomes. (B) Mito-tracker fluorescent dye was used to stain mitochondria of cells 
treated with R18 DOPE liposomes containing pHLIP (a). pHLIP mediated uptake of R18 liposomes show 
specific staining of mitochondria (b).  An overlay of (a) & (b) is shown in panel (c) to be certain that the 
staining pattern of R18 is truly due to mitochondrial localization. On the panel (d) a zoom-in picture of 
mitochondria stained with R18 liposome is shown. (C) Adherent A549 cells were treated with Rho-PE 
DOPE liposomes with (c & d: ‘5:5’ formulation) or without pHLIP (a & b: ‘0:10’) in PBS at pH 6.3 for 
30 min. Both light (a, c) and fluorescent images (b, d) were taken immediately after washing. (D) 
Adherent A549 cells were treated with fluorescein DOPC liposomes with 5 mol % of pHLIP-PEG-lipids 
(PBS, pH 6.2, 1 hr). Staining of plasma membrane by FITC-lipids of liposomes shown on panel (a) is 
confirmed by staining of the plasma membrane of the same cells by Texas Red-labeled wheat germ 
agglutinin, as shown on panel (b). (E) Adherent A549 cells were treated with nanogold-containing DOPE 
liposomes with or without pHLIP in serum-free DMEM (pH 6.5, 15 min). After fixation and silver 
enhancement, cells were visualized under the light microscope (a: no pHLIP; b: with pHLIP). Liposomes 
containing 10 mol % of pHLIP delivered more nanogold to cells (image b) than control liposomes 
without pHLIP (image a). The scale bar is 20 µm in all images. 
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Delivery of an encapsulated cargo 
The main goal in effective use of liposomes, as a delivery agent, is to deliver and release polar payload 
into cells. Therefore, we investigated pHLIP-mediated liposomal delivery of an encapsulated cargo. 
Propidium iodide (PI), a membrane-impermeable DNA staining dye, was encapsulated in liposomes to 
serve as the model payload. Adherent A549 cells were incubated in serum free DMEM at pH 6.5, for 1 hr 
with fluorescein-labeled DOPE liposomes loaded with PI, with or without pHLIP in liposomal coating 
(Figure 6). Fluorescein (Figure 6A-B) and PI (Figure 6C-D) fluorescent images, taken after 1 hour 
treatment, evidently demonstrate that pHLIP-containing liposomes delivered much more PI to the nuclei 
than control liposomes. Further, more staining of cellular membranes was observed on cells treated with 
pHLIP-containing liposomes. According to the data presented on Figure 4, endocytosis is responsible 
only for ~ 50% of the pHLIP-mediated cellular uptake of liposomes and the other 50% are due to the 
pHLIP-induced direct fusion with plasma membrane (Figure 4D). Fusion is much faster than endocytosis. 
Our study shows that the internalization of liposomes was observed even after 15 min treatment (Figure 
4). Thus, we assume that the release of PI encapsulated in liposomes occurred as a result of fusion of 
liposomes with plasma membrane. These results are consistent with the notion that pHLIP can promote 
membrane fusion and lipids exchange, leading to enhancement of payload release.  
 
 
 
 
 
Delivery of liposomal ceramide inhibites proliferation of cancer cells 
Our data suggest that pHLIP can enhance cellular delivery of liposomes. Can this approach be applied 
toward the delivery of cytotoxic agents of therapeutic potential? It was demonstrated that PEGylated 
liposomes containing short chain C6 ceramide can induce apoptosis in human breast cancer cells [31-33]. 
We prepared pHLIP-containing liposomes with 30 mol % of C6 ceramide to investigate whether pHLIP 
can enhance the cellular delivery of this cytotoxic signaling lipid. Cryo-TEM images confirmed the 
integrity of the ceramide- and pHLIP-containing liposomes (Figure 7A, B). The size of the liposomes 
were measured immediately after extrusion (Figure 7C) and then monitored for 3 days (Figure 7D). 
Ceramide-containing liposomes with pHLIP were slightly larger (~ 125 nm in diameter) than liposomes 
without pHLIP (~ 95 nm in diameter). Nonetheless, aggregation of pHLIP-containing liposomes was not 
significant during the 3-day follow-up period. These data confirmed that the ceramide liposomes were 
uniform in size and stable in solution.  
 
The cytotoxic effects of ceramide-containing liposomes were evaluated in anti-proliferation assay. First, 
A549 cells in suspension were incubated with ceramide-liposomes with or without pHLIP, at pH 8.0, or 
pH 6.1, for 60 min in a phosphate buffer. pH 8 was used to enhance pH-dependent effect of pHLIP-coated 
Figure 6. pHLIP-mediated liposomal delivery 
of propidium iodide (PI). Adherent A549 cells 
were incubated in serum free DMEM (pH 6.5, 1 
hr) with fluorescein-labeled DOPE liposomes 
loaded with PI, with or without pHLIP (‘5:5’ or 
‘0:10’ formulation) in liposomal coating. 
Fluorescent images of cells treated with pHLIP-
containing liposomes (A & C) or control 
liposomes without pHLIP (B & D) are shown 
side by side. The fluorescent images of the same 
cells were taken with two filter settings: green - 
fluorescein fluorescence; red - PI fluorescence. 
The exposure time is 172 ms for A & B and 80 
ms for C & D. The scale bar is 20 µm. 
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liposomes. After washing, treated cells were grown on 96-well plates (at ~ 5000 cells per well) for 3 days 
before viable cell populations were counted by MTS colorimetric assay. When the liposome treatment 
was carried out at pH 8, control liposomes exhibit some toxicity to the cells, while pHLIP-coated 
liposomes show practically no toxicity (Figure 7F). By contrast, when the treatment was carried out at pH 
6.1, significant differences in cell viability was observed between cells treated with pHLIP- and ceramide-
containing liposomes (< 10% of cell survival), and cells treated with control liposomes containing 
ceramide, but no pHLIP (~ 60% of cell survival) (Figure 7E). Compared to untreated cell population, the 
treatment with ceramide-containing liposomes at low pH alone inhibited <40% of cell proliferation, 
whereas the presence of pHLIP in liposome coat contributed to an additional 50% of inhibition, 
presumably by elevating the intracellular concentration of C6 ceramide. Thus, pHLIP enhances delivery 
of liposomal ceramide to cells at low pH, which induces cell death.  
   
 
 
DISCUSSION 
pH-sensitive liposomes were designed to mimic the highly efficient intracellular delivery systems utilized 
by viruses and pathogenic organisms. There are two main pathways of viruses entry into cells: direct 
fusion with plasma membrane and endocytotic uptake by host cells [34-41]. Membrane fusion also occurs 
in  membrane trafficking, including neurotransmitter release in synaptic transmission, gamete formation 
in sexual reproduction, and myotube formation in organ development [42]. In all these cases, two distinct 
membranes have to come close to each other, merge, mix, which leads to the fusion. This process is 
triggered and regulated by fusion proteins. The entire fusion machinery of viruses is a single fusion 
protein within their own membrane, while intracellular fusion machines consist of several proteins located 
in both membranes to be fused. Despite the differences between viral and intracellular fusion proteins, 
their main role is to bring two individual membranes together [34, 37, 42-45]. Only upon activation, often 
by low pH in endosomes, does the fusion peptides (which are a part of the fusion protein) become 
exposed and available for insertion into the target membrane [42]. The process of membrane fusion 
mediated by fusion proteins can be as fast as 8 ms [46]. 
 
Figure 7. pHLIP-mediated delivery of liposomal 
ceramide inhibits proliferation of cancer cells at 
low pH. (A-B) Liposomes containing 30 mol % of C-
6 ceramide were characterized using Cryo-TEM: 
control liposomes without pHLIP and liposomes 
containing pHLIP are shown on panels A and B, 
respectively. (C) DLS was used to investigate the 
changes of liposome size with time. The size of the 
liposomes was measured immediately after liposome 
extrusion and monitored for 3 days. (D) A549 cells in 
suspension were incubated with ceramide liposomes 
(with or without pHLIP) at pH 8.0 or 6.1 for 60 min 
in a phosphate buffer. After washing, treated cells 
were grown in 96-well plates for 3 days before viable 
cell populations were estimated via MTS assays. 
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Figure 8. Schematic presentation of pHLIP/PEG coated liposomes (A) and their interaction with 
cellular membranes (B). The encapsulated model payload molecules and the head-groups of fluorescent 
lipids are shown in red.  
 
Inspired by the action of fusion peptides, which insert into the target membrane to induce fusion, we 
decorated PEG-coated liposomes with pHLIP (Figure 8A). Our data indicate that pHLIP adopts random 
coil configuration in aqueous solution at normal and high pH [21]. We assume that on the surface of 
liposomes coated with PEG polymer, pHLIP would adopt coil configuration as well. Our estimation of 
volume occupied by single pHLIP coil according to the freely-jointed model of polymer physics and the 
surface area on the liposomes available for the coating indicates that about 50% of liposome surface is 
coated with pHLIP peptides in the case of ‘5:5’ liposome formulation. At pH<7.0 Asp/Glu residues are 
protonated, which increases peptide hydrophobicity and affinity to membrane and leads to the peptide 
insertion into lipid bilayer and formation of a stable transmembrane helix. The biophysical studies 
indicate that process on model membrane could be completed within 60 sec [47]. Our biophysical inter-
liposomal assays clearly demonstrates that indeed pHLIP induces fusion of both fusogenic (DOPE-based) 
and non-fusogenic (DOPC-based) PEG-liposomes with POPC vesicles at low pH. The content of 
liposomes is mixing in a result of the fusion. Experiments on cultured cells further confirmed pHLIP’s 
ability to induce fusion and lipid mixing between PEG-liposomes and biological membranes, evidenced 
by the following: i) pHLIP-induced  cellular uptake of DOPE- and DOPC-based PEG-liposomes are 
dependent on acidic extracellular pH, ii) fluorescent lipid probes (or nanogold-lipid conjugates) brought in 
by the liposomes are distributed throughout the cell. Important that lipid mixing occurs not in a result of 
flip-flopping of fluorescent lipids and fatty acids, but in a result of membrane fusion, which leads to the 
efficient cytoplasmic delivery of liposomal payload. In addition to delivering probes and model cargos we 
also showed that, at low extracellular pH (pH 6.0), pHLIP can enhance the biological effect of PEGylated 
liposomes containing short chain C6 ceramide, which induces apoptosis and cell death [48, 49]. We 
concluded that the presence of up to 5 mol % of PEG polymer in the liposomal coatings favors pHLIP 
interaction with the inter-membrane surface over its own intra-liposomal surface. The amount of pHLIP 
peptide in the liposome coat correlates with the degree of fusion: the more pHLIP, the more fusion.  
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Our data indicate that there might be several routes of liposome entry into the cell: i) direct fusion with 
plasma membrane, and ii) endocytotic uptake of liposomes, and then, fusion with endosomal membrane 
(Figure 8B). In both cases, the first event is the insertion of pHLIP peptides into target membrane 
triggered by reduced pH, bringing liposomal and cellular membranes close to each other, which can 
induce fusion of liposome with cellular membrane. Since there are many pHLIP peptides on a liposome 
surface, their simultaneous insertion might lead to plasma membrane raffling and blebbing, which may 
trigger internalization of liposomes. It is well documented that pHLIP shows direct spontaneous insertion 
into membrane of liposomes and cells in vitro and in vivo, and this process does not involve receptor 
interaction  [19, 50, 51]. Therefore, we assume that plasma membrane raffling and blebbing might 
promote macropinocytosis, which is an endocytic route of cellular internalization not associated with the 
activation of a particular receptor on the cellular surface [52-54]. More detailed investigation is needed to 
confirm that pHLIP-triggered endocytotic uptake of liposomes occur via macropinocytosis. When 
endosomes with encapsulated liposomes detach from the plasma membrane inside a cell, they undergo 
acidification. Low pH (5.0-5.5) inside endosomes would promote even more efficient insertion of pHLIP 
into the endosomal membrane, leading to lipid mixing and fusion. As a result, liposomal payload is 
released into the cytoplasm and liposomal lipids could be found in the membrane of various cellular 
compartments.  
 
pHLIP-coated liposomes represent a novel type of pH-sensitive “fusogenic” liposomes. In pHLIP-coated 
liposomes, the fusogenic properties are determined not only by the choice of lipids, but also by the 
presence of membrane-inserting peptides on the liposome surface, as in some pathogens. The energy of 
membrane-associated folding of pHLIP is utilized to bring liposomal and cellular membranes close to 
each other to induce lipid mixing, or membrane blebbing and raffling. Since extracellular acidity is 
associated with the development of various pathological states, such as solid tumors, ischemic stroke, 
neurotrauma, epileptic seizure, inflammation, infection, wounds, cystic fibrosis and others, pHLIP-coated 
liposomes could be used to deliver and release various diagnostic and therapeutic agents to these sites of 
disease. 
 
CONCLUSIONS 
We introduced new formulation of pHLIP-PEG-coated liposomes. pHLIP promotes cellular uptake of 
both fusogenic (DOPE-based) and non-fusogenic (DOPC-based) liposomes at low pH. Our data indicate 
that about 50% of cellular uptake of pHLIP-PEG-coated liposomes at low pH could be attributed to the 
direct fusion with plasma membrane and about 50% due to the endocytotic pathway of cellular entry. 
Lipids and fatty acids conjugated with various reporters (such as fluorescent dyes or gold nanoparticles), 
when incorporated  into pHLIP-PEG-coated liposomes,  were distributed to various cellular 
compartments, including  mitochondrial, nuclear and plasma membranes, at the same time, encapsulated 
in liposome polar cargo, such as propidium iodide, was delivered  to nuclear DNA  at low pH. We show 
that pHLIP-PEG-coated liposomes containing C6-ceramide induced cell death much more effectively 
(~90% inhibition) than PEG-liposomes containing no pHLIP in their coating (~40% inhibition) at low pH. 
Since low extracellular pH is a characteristic feature of many pathological states, we assume that pHLIP-
PEG-coated liposomes could be used for selective delivery and cytoplasmic release of diagnostic and 
therapeutic agents. 
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